Zhiyong Xiong
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 15, 2025
Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma.Daojia Miao, Jian Shi, Diaoyi Tan
|Aug 29, 2024
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.Diaoyi Tan, Daojia Miao, Chuanyi Zhao
|Jul 22, 2024
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.Diaoyi Tan, Daojia Miao, Chuanyi Zhao
|Aug 25, 2023
The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling.Jian Shi, Daojia Miao, Qingyang Lv
Pageof 1
